logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shinji Tamura

University of Osaka
H指数:43
被引数:7,752

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Letter: serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination-authors' reply
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
2022-03-310
PRE
Myojin, Yuta; Hikita, Hayato; Tahata, Yuki; Doi, Akira; Kato, Seiya; Sasaki, Yoichi; Shirai, Kumiko; Sakane, Sadatsugu; Yamada, Ryoko; Kodama, Takahiro; Hagiwara, Hideki; Imai, Yasuharu; Hiramatsu, Naoki; Tamura, Shinji; Yamamoto, Keiji; Ohkawa, Kazuyoshi; Hijioka, Taizo; Fukui, Hiroyuki; Doi, Yoshinori; Yamada, Yukinori; Yakushijin, Takayuki; Mita, Eiji; Sakamori, Ryotaro; Tatsumi, Tomohide; Takehara, Tetsuo
Letter: evaluation and proposed reclassification of HCC prediction model of Tahata et al. in chronic hepatitis C genotype 4 patient. Authors' reply
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
2021-12-301
PREAI
Tahata, Yuki; Sakamori, Ryotaro; Yamada, Ryoko; Kodama, Takahiro; Hikita, Hayato; Hagiwara, Hideki; Imai, Yasuharu; Hiramatsu, Naoki; Tamura, Shinji; Yamamoto, Keiji; Oshita, Masahide; Ohkawa, Kazuyoshi; Hijioka, Taizo; Fukui, Hiroyuki; Ito, Toshifumi; Doi, Yoshinori; Yamada, Yukinori; Yakushijin, Takayuki; Yoshida, Yuichi; Tatsumi, Tomohide; Takehara, Tetsuo
Serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
2021-11-2317
PREAI
Myojin, Yuta; Hikita, Hayato; Tahata, Yuki; Doi, Akira; Kato, Seiya; Sasaki, Yoichi; Shirai, Kumiko; Sakane, Sadatsugu; Yamada, Ryoko; Kodama, Takahiro; Hagiwara, Hideki; Imai, Yasuharu; Hiramatsu, Naoki; Tamura, Shinji; Yamamoto, Keiji; Ohkawa, Kazuyoshi; Hijioka, Taizo; Fukui, Hiroyuki; Doi, Yoshinori; Yamada, Yukinori; Yakushijin, Takayuki; Mita, Eiji; Sakamori, Ryotaro; Tatsumi, Tomohide; Takehara, Tetsuo
Prediction model for hepatocellular carcinoma occurrence in patients with hepatitis C in the era of direct-acting anti-virals
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
2021-10-0721
PRE
Tahata, Yuki; Sakamori, Ryotaro; Yamada, Ryoko; Kodama, Takahiro; Hikita, Hayato; Hagiwara, Hideki; Imai, Yasuharu; Hiramatsu, Naoki; Tamura, Shinji; Yamamoto, Keiji; Oshita, Masahide; Ohkawa, Kazuyoshi; Hijioka, Taizo; Fukui, Hiroyuki; Ito, Toshifumi; Doi, Yoshinori; Yamada, Yukinori; Yakushijin, Takayuki; Yoshida, Yuichi; Tatsumi, Tomohide; Takehara, Tetsuo
Clinical course of hepatitis C virus-positive patients with decompensated liver cirrhosis in the era of direct-acting antiviral treatment

在直接抗病毒治疗时代，丙型肝炎病毒阳性的失代偿期肝硬化患者的临床过程

HEPATOLOGY RESEARCH
IF3.4
2021-03-098
PREAI
Maesaka, Kazuki; Sakamori, Ryotaro; Yamada, Ryoko; Tahata, Yuki; Oshita, Masahide; Hagiwara, Hideki; Sakakibara, Mitsuru; Tamura, Shinji; Hiramatsu, Naoki; Inada, Masami; Iio, Sadaharu; Ito, Toshifumi; Yakushijin, Takayuki; Doi, Yoshinori; Kodama, Takahiro; Hikita, Hayato; Tatsumi, Tomohide; Takehara, Tetsuo
Hepatocellular carcinoma occurrence does not differ between interferon-based and interferon-free treatment with liver histological assessment

肝细胞癌的发生在基于干扰素和无干扰素治疗与肝组织学评估之间没有差异

HEPATOLOGY RESEARCH
IF3.4
2020-01-089
PREAI
Tahata, Yuki; Sakamori, Ryotaro; Urabe, Ayako; Yamada, Ryoko; Ohkawa, Kazuyoshi; Hiramatsu, Naoki; Hagiwara, Hideki; Masahide, Oshita; Hijioka, Taizo; Tamura, Shinji; Imai, Yasuharu; Kodama, Takahiro; Hikita, Hayato; Tatsumi, Tomohide; Takehara, Tetsuo
Predictive factors of anemia during sofosbuvir and ribavirin therapy for genotype 2 chronic hepatitis C patients

基因2型慢性丙型肝炎患者索非布韦和利巴韦林治疗期间贫血的预测因素

HEPATOLOGY RESEARCH
IF3.4
2019-05-236
PREAI
Urabe, Ayako; Sakamori, Ryotaro; Tahata, Yuki; Yamada, Ryoko; Imai, Yasuharu; Hagiwara, Hideki; Tamura, Shinji; Fukui, Hiroyuki; Yamada, Yukinori; Kaneko, Akira; Hijioka, Taizo; Kodama, Takahiro; Hikita, Hayato; Tatsumi, Tomohide; Takehara, Tetsuo
Incidence and risk factors of hepatocellular carcinoma change over time in patients with hepatitis C virus infection who achieved sustained virologic response

获得持续病毒学应答的丙型肝炎病毒感染患者肝癌发生率及危险因素随时间的变化

HEPATOLOGY RESEARCH
IF3.4
2019-02-0632
PREAI
Yamada, Ryoko; Hiramatsu, Naoki; Oze, Tsugiko; Urabe, Ayako; Tahata, Yuki; Morishita, Naoki; Kodama, Takahiro; Hikita, Hayato; Sakamori, Ryotaro; Yakushijin, Takayuki; Yamada, Akira; Hagiwara, Hideki; Mita, Eiji; Oshita, Masahide; Itoh, Toshifumi; Fukui, Hiroyuki; Inui, Yoshiaki; Hijioka, Taizo; Inada, Masami; Katayama, Kazuhiro; Tamura, Shinji; Inoue, Atsuo; Imai, Yasuharu; Tatsumi, Tomohide; Hamasaki, Toshimitsu; Hayashi, Norio; Takehara, Tetsuo

研究方向

暂未获取到该数据
N
Nobuhito Imanaka
H 指数:42论文数:536被引数:9,561
S
Shinichi Kiso
H 指数:36论文数:200被引数:4,474
N
Norio Hayashi
H 指数:90论文数:926被引数:3.3万
G
Gin‐ya Adachi
H 指数:49论文数:587被引数:1.1万
Y
Yasuharu Imai
H 指数:42论文数:326被引数:8,135
T
Tetsuo Takehara
H 指数:74论文数:979被引数:2.3万
H
Hideki Hagiwara
H 指数:34论文数:216被引数:4,269
N
Naoki Hiramatsu
H 指数:42论文数:242被引数:6,836
T
Tomohide Tatsumi
H 指数:54论文数:503被引数:1.0万
T
Takayuki Yakushijin
H 指数:29论文数:213被引数:2,607